25 XP   0   0   10

DexCom Inc
Buy, Hold or Sell?

Let's analyse Dexcom together

PenkeI guess you are interested in DexCom Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of DexCom Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about DexCom Inc

I send you an email if I find something interesting about DexCom Inc.

Quick analysis of Dexcom (30 sec.)










What can you expect buying and holding a share of Dexcom? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$4.97
Expected worth in 1 year
$4.94
How sure are you?
85.0%

+ What do you gain per year?

Total Gains per Share
$-0.03
Return On Investment
0.0%

For what price can you sell your share?

Current Price per Share
$134.00
Expected price per share
$127.37 - $142.00
How sure are you?
50%

1. Valuation of Dexcom (5 min.)




Live pricePrice per Share (EOD)

$134.00

Intrinsic Value Per Share

$-1.73 - $9.08

Total Value Per Share

$3.24 - $14.05

2. Growth of Dexcom (5 min.)




Is Dexcom growing?

Current yearPrevious yearGrowGrow %
How rich?$2b$2.1b$67.1m3.1%

How much money is Dexcom making?

Current yearPrevious yearGrowGrow %
Making money$135.3m$85.3m$50m37.0%
Net Profit Margin14.3%11.8%--

How much money comes from the company's main activities?

3. Financial Health of Dexcom (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#19 / 334

Most Revenue
#20 / 334

Most Profit
#18 / 334

What can you expect buying and holding a share of Dexcom? (5 min.)

Welcome investor! Dexcom's management wants to use your money to grow the business. In return you get a share of Dexcom.

What can you expect buying and holding a share of Dexcom?

First you should know what it really means to hold a share of Dexcom. And how you can make/lose money.

Speculation

The Price per Share of Dexcom is $134.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Dexcom.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Dexcom, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.97. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.20 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Dexcom.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.620.5%0.320.2%0.200.1%0.200.1%0.080.1%
Usd Book Value Change Per Share-0.34-0.3%-0.010.0%-0.20-0.1%0.160.1%0.120.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.34-0.3%-0.010.0%-0.20-0.1%0.160.1%0.120.1%
Usd Price Per Share124.09-115.52-194.98-260.29-167.07-
Price to Earnings Ratio50.34-125.64-233.49-140.08-132.16-
Price-to-Total Gains Ratio-365.04--19.68--87.78-1,005.27-1,283.09-
Price to Book Ratio24.95-22.67-38.89-67.91-92.22-
Price-to-Total Gains Ratio-365.04--19.68--87.78-1,005.27-1,283.09-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share134
Number of shares7
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.16
Usd Total Gains Per Share-0.010.16
Gains per Quarter (7 shares)-0.061.14
Gains per Year (7 shares)-0.224.55
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-0-1005-5
20-0-10090
30-1-100145
40-1-1001810
50-1-1002315
60-1-1002720
70-2-1003225
80-2-1003630
90-2-1004135
100-2-1004640

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%17.03.00.085.0%22.018.00.055.0%22.054.02.028.2%
Book Value Change Per Share2.02.00.050.0%7.05.00.058.3%15.05.00.075.0%34.06.00.085.0%45.033.00.057.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.078.00.0%
Total Gains per Share2.02.00.050.0%7.05.00.058.3%15.05.00.075.0%34.06.00.085.0%45.033.00.057.7%

Fundamentals of Dexcom

About DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2024-04-11 06:24:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of DexCom Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Dexcom earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Dexcom to the Medical Devices industry mean.
  • A Net Profit Margin of 24.8% means that $0.25 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of DexCom Inc:

  • The MRQ is 24.8%. The company is making a huge profit. +2
  • The TTM is 14.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ24.8%TTM14.3%+10.5%
TTM14.3%YOY11.8%+2.5%
TTM14.3%5Y12.1%+2.2%
5Y12.1%10Y0.5%+11.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ24.8%-12.4%+37.2%
TTM14.3%-20.4%+34.7%
YOY11.8%-14.8%+26.6%
5Y12.1%-21.3%+33.4%
10Y0.5%-25.0%+25.5%
1.1.2. Return on Assets

Shows how efficient Dexcom is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Dexcom to the Medical Devices industry mean.
  • 4.1% Return on Assets means that Dexcom generated $0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of DexCom Inc:

  • The MRQ is 4.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.1%TTM2.1%+2.0%
TTM2.1%YOY1.7%+0.5%
TTM2.1%5Y1.7%+0.4%
5Y1.7%10Y-1.0%+2.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1%-4.1%+8.2%
TTM2.1%-4.7%+6.8%
YOY1.7%-4.8%+6.5%
5Y1.7%-4.0%+5.7%
10Y-1.0%-5.2%+4.2%
1.1.3. Return on Equity

Shows how efficient Dexcom is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Dexcom to the Medical Devices industry mean.
  • 12.4% Return on Equity means Dexcom generated $0.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of DexCom Inc:

  • The MRQ is 12.4%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 6.4%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ12.4%TTM6.4%+6.0%
TTM6.4%YOY4.1%+2.2%
TTM6.4%5Y4.5%+1.8%
5Y4.5%10Y-0.7%+5.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ12.4%-4.2%+16.6%
TTM6.4%-5.8%+12.2%
YOY4.1%-5.7%+9.8%
5Y4.5%-6.3%+10.8%
10Y-0.7%-7.1%+6.4%

1.2. Operating Efficiency of DexCom Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Dexcom is operating .

  • Measures how much profit Dexcom makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Dexcom to the Medical Devices industry mean.
  • An Operating Margin of 24.3% means the company generated $0.24  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of DexCom Inc:

  • The MRQ is 24.3%. The company is operating efficient. +1
  • The TTM is 18.4%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ24.3%TTM18.4%+5.9%
TTM18.4%YOY13.0%+5.4%
TTM18.4%5Y12.9%+5.5%
5Y12.9%10Y0.9%+12.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ24.3%-24.3%+48.6%
TTM18.4%-16.4%+34.8%
YOY13.0%-13.7%+26.7%
5Y12.9%-19.9%+32.8%
10Y0.9%-24.5%+25.4%
1.2.2. Operating Ratio

Measures how efficient Dexcom is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.79 means that the operating costs are $0.79 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of DexCom Inc:

  • The MRQ is 0.790. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.842. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.790TTM0.842-0.052
TTM0.842YOY0.870-0.027
TTM0.8425Y0.875-0.032
5Y0.87510Y0.998-0.123
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7901.442-0.652
TTM0.8421.439-0.597
YOY0.8701.431-0.561
5Y0.8751.436-0.561
10Y0.9981.374-0.376

1.3. Liquidity of DexCom Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Dexcom is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 2.84 means the company has $2.84 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of DexCom Inc:

  • The MRQ is 2.844. The company is able to pay all its short-term debts. +1
  • The TTM is 2.520. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.844TTM2.520+0.324
TTM2.520YOY3.939-1.419
TTM2.5205Y4.856-2.336
5Y4.85610Y4.490+0.365
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8442.726+0.118
TTM2.5202.732-0.212
YOY3.9393.510+0.429
5Y4.8563.617+1.239
10Y4.4903.499+0.991
1.3.2. Quick Ratio

Measures if Dexcom is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Dexcom to the Medical Devices industry mean.
  • A Quick Ratio of 3.77 means the company can pay off $3.77 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of DexCom Inc:

  • The MRQ is 3.772. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.446. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.772TTM3.446+0.326
TTM3.446YOY5.464-2.018
TTM3.4465Y6.667-3.221
5Y6.66710Y5.470+1.197
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7721.491+2.281
TTM3.4461.633+1.813
YOY5.4642.113+3.351
5Y6.6672.295+4.372
10Y5.4702.255+3.215

1.4. Solvency of DexCom Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Dexcom assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Dexcom to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.67 means that Dexcom assets are financed with 67.0% credit (debt) and the remaining percentage (100% - 67.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of DexCom Inc:

  • The MRQ is 0.670. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.653. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.670TTM0.653+0.016
TTM0.653YOY0.592+0.062
TTM0.6535Y0.611+0.042
5Y0.61110Y0.488+0.123
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6700.389+0.281
TTM0.6530.386+0.267
YOY0.5920.335+0.257
5Y0.6110.442+0.169
10Y0.4880.461+0.027
1.4.2. Debt to Equity Ratio

Measures if Dexcom is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Dexcom to the Medical Devices industry mean.
  • A Debt to Equity ratio of 202.8% means that company has $2.03 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of DexCom Inc:

  • The MRQ is 2.028. The company is just not able to pay all its debts with equity.
  • The TTM is 1.914. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.028TTM1.914+0.115
TTM1.914YOY1.459+0.454
TTM1.9145Y1.605+0.308
5Y1.60510Y1.140+0.465
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0280.551+1.477
TTM1.9140.554+1.360
YOY1.4590.479+0.980
5Y1.6050.622+0.983
10Y1.1400.674+0.466

2. Market Valuation of DexCom Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Dexcom generates.

  • Above 15 is considered overpriced but always compare Dexcom to the Medical Devices industry mean.
  • A PE ratio of 50.34 means the investor is paying $50.34 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of DexCom Inc:

  • The EOD is 54.361. Based on the earnings, the company is expensive. -2
  • The MRQ is 50.340. Based on the earnings, the company is expensive. -2
  • The TTM is 125.635. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD54.361MRQ50.340+4.020
MRQ50.340TTM125.635-75.295
TTM125.635YOY233.493-107.858
TTM125.6355Y140.079-14.443
5Y140.07910Y132.158+7.920
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD54.361-1.077+55.438
MRQ50.340-1.704+52.044
TTM125.635-2.081+127.716
YOY233.493-2.978+236.471
5Y140.079-2.379+142.458
10Y132.158-1.726+133.884
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of DexCom Inc:

  • The EOD is 171.796. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 159.091. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 115.199. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD171.796MRQ159.091+12.705
MRQ159.091TTM115.199+43.892
TTM115.199YOY-368.652+483.851
TTM115.1995Y50.886+64.313
5Y50.88610Y-441.043+491.929
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD171.796-0.932+172.728
MRQ159.091-1.578+160.669
TTM115.199-2.973+118.172
YOY-368.652-6.318-362.334
5Y50.886-5.307+56.193
10Y-441.043-5.171-435.872
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Dexcom is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 24.95 means the investor is paying $24.95 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of DexCom Inc:

  • The EOD is 26.941. Based on the equity, the company is expensive. -2
  • The MRQ is 24.949. Based on the equity, the company is expensive. -2
  • The TTM is 22.670. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD26.941MRQ24.949+1.992
MRQ24.949TTM22.670+2.278
TTM22.670YOY38.886-16.216
TTM22.6705Y67.914-45.244
5Y67.91410Y92.223-24.309
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD26.9411.876+25.065
MRQ24.9492.372+22.577
TTM22.6702.434+20.236
YOY38.8863.217+35.669
5Y67.9143.893+64.021
10Y92.2234.245+87.978
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of DexCom Inc.

3.1. Institutions holding DexCom Inc

Institutions are holding 102.985% of the shares of DexCom Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc11.53450.1205444674632784580.6302
2023-12-31BlackRock Inc8.48890.103632726186-16643-0.0508
2023-12-31Baillie Gifford & Co Limited.4.28531.624516520313-162191-0.9722
2023-12-31State Street Corporation4.20180.0978161985981631391.0174
2023-12-31Capital Research Global Investors3.96770.46715296032269529621.39
2023-12-31Sands Capital Management, LLC3.90615.679615058806139813610.2348
2023-12-31Capital World Investors2.40680.204892786855256092130.6643
2023-12-31Geode Capital Management, LLC2.31310.115589172551882192.1562
2023-12-31FMR Inc2.10440.07738112737-904388-10.0297
2023-12-31Nuveen Asset Management, LLC1.94340.29927492292-257773-3.3261
2023-12-31Artisan Partners Limited Partnership1.53051.127359003083672471164.8447
2023-12-31JPMorgan Chase & Co1.46620.067456526192423524.4795
2023-12-31T. Rowe Price Associates, Inc.1.42660.09175499896215793364.5708
2023-12-31American Century Companies Inc1.37740.4535309943-62743-1.1678
2023-12-31Morgan Stanley - Brokerage Accounts1.32340.0558510180067786515.3227
2023-12-31Goldman Sachs Group Inc1.28340.055149475902755085125.6592
2023-12-31Bank of America Corp1.21070.05844667598176628460.8788
2023-12-31Blair William & Co1.1591.88934468004-39149-0.8686
2023-12-31UBS Asset Mgmt Americas Inc1.13660.213943818482901557.0913
2023-12-31NORGES BANK1.12920.0944435311263200816.9844
Total 58.19512.8961224351085+20730606+9.2%

3.2. Funds holding DexCom Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Performer (AFRIS)16.72840.071164490716644907160
2024-02-29Vanguard Total Stock Mkt Idx Inv3.14390.0912120160-26788-0.2205
2024-02-29Vanguard Institutional 500 Index Trust2.50180.10389644805968941.0148
2023-12-31American Funds Growth Fund of Amer A2.49830.47999631302476720098.0078
2023-12-31Capital Group Growth Fnd of Amer Comp2.49830.47999631302476720098.0078
2024-02-29Vanguard Mid Cap Index Institutional2.23960.62048633908-22999-0.2657
2024-03-28Invesco QQQ Trust1.87450.3861722633286660.1201
2023-12-31Sands Capital Global Growth Equity1.73855.53276702096113449020.3766
2024-02-29AF High Growth (AFRIS)1.27150.0675490170949017090
2024-03-28SPDR® S&P 500 ETF Trust1.2180.12124695432274800.5887
2024-02-29Fidelity 500 Index1.2020.10354633956466311.0165
2023-12-31Sands Capital Select Growth TE Inst EQ1.08336.7333417647438830031323.1301
2024-03-28iShares Core S&P 500 ETF1.03670.1213996679294400.7421
2024-02-29Vanguard Growth Index Investor0.93170.18593591791319280.8969
2024-01-31CREF Growth R10.90771.21263499365-32469-0.9193
2023-12-31VA CollegeAmerica Amcap 529A0.85360.5083329089400
2023-12-31Capital Group AMCAP Composite0.85360.5083329089400
2024-03-28Health Care Select Sector SPDR® ETF0.75410.97652907063-4689-0.161
2024-02-29Vanguard Mid-Cap Growth ETF0.7191.31842771806164790.5981
2024-02-29Vanguard Institutional Index I0.66020.10352545240-10215-0.3997
Total 44.714719.7239172381924+84104676+48.8%

3.3. Insider Transactions

Insiders are holding 0.424% of the shares of DexCom Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-28Michael Jon BrownSELL2624140.04
2024-03-25Sadie SternSELL4137140
2024-03-12Jacob Steven LeachSELL14639134.41
2024-03-12Jereme M SylvainSELL11661134.41
2024-03-12Kevin R SayerSELL81007133.36
2024-03-12Sadie SternSELL20321133.61
2024-02-20Jereme M SylvainSELL3363116.73
2024-01-16Sadie SternSELL2902123.63
2024-01-16Steven R AltmanSELL1568122.86
2024-01-16Kevin R SayerSELL37325123.63
2024-01-16Jereme M SylvainSELL2734123.63
2024-01-16Jacob Steven LeachSELL3978123.63
2023-12-12Steven R AltmanSELL3000120
2023-12-11Sadie SternSELL392117.66
2023-12-01Michael Jon BrownSELL3612114.56
2023-11-24Steven Robert PacelliSELL411110.8
2023-11-22Sadie SternSELL1176110
2023-11-15Steven R AltmanSELL1000101.26
2023-11-08Barry J ReganSELL201995.22
2023-10-23Steven Robert PacelliSELL41185.75

4. Summary

4.1. Key Performance Indicators

The key performance indicators of DexCom Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.340-0.008-98%-0.199-41%0.163-309%0.119-386%
Book Value Per Share--4.9745.123-3%4.937+1%4.119+21%2.434+104%
Current Ratio--2.8442.520+13%3.939-28%4.856-41%4.490-37%
Debt To Asset Ratio--0.6700.653+3%0.592+13%0.611+10%0.488+37%
Debt To Equity Ratio--2.0281.914+6%1.459+39%1.605+26%1.140+78%
Dividend Per Share----0%-0%-0%-0%
Eps--0.6160.321+92%0.200+208%0.198+211%0.078+687%
Free Cash Flow Per Share--0.1950.301-35%0.180+9%0.155+26%0.084+131%
Free Cash Flow To Equity Per Share---1.3240.099-1438%-0.145-89%0.170-880%0.167-894%
Gross Profit Margin--1.0001.0000%0.638+57%0.928+8%0.964+4%
Intrinsic Value_10Y_max--9.079--------
Intrinsic Value_10Y_min---1.730--------
Intrinsic Value_1Y_max--0.716--------
Intrinsic Value_1Y_min--0.252--------
Intrinsic Value_3Y_max--2.300--------
Intrinsic Value_3Y_min--0.394--------
Intrinsic Value_5Y_max--4.061--------
Intrinsic Value_5Y_min--0.135--------
Market Cap51659011072.000+0%51609031000.00048875716500.000+6%83325967500.000-38%106005052754.976-51%67236848828.496-23%
Net Profit Margin--0.2480.143+74%0.118+110%0.121+105%0.005+4716%
Operating Margin--0.2430.184+32%0.130+86%0.129+88%0.009+2653%
Operating Ratio--0.7900.842-6%0.870-9%0.875-10%0.998-21%
Pb Ratio26.941+7%24.94922.670+10%38.886-36%67.914-63%92.223-73%
Pe Ratio54.361+7%50.340125.635-60%233.493-78%140.079-64%132.158-62%
Price Per Share134.000+7%124.090115.520+7%194.978-36%260.287-52%167.066-26%
Price To Free Cash Flow Ratio171.796+7%159.091115.199+38%-368.652+332%50.886+213%-441.043+377%
Price To Total Gains Ratio-394.189-8%-365.037-19.680-95%-87.783-76%1005.266-136%1283.092-128%
Quick Ratio--3.7723.446+9%5.464-31%6.667-43%5.470-31%
Return On Assets--0.0410.021+92%0.017+145%0.017+134%-0.010+125%
Return On Equity--0.1240.064+95%0.041+199%0.045+174%-0.007+105%
Total Gains Per Share---0.340-0.008-98%-0.199-41%0.163-309%0.119-386%
Usd Book Value--2068600000.0002167475000.000-5%2100375000.000-2%1698890000.000+22%993595000.000+108%
Usd Book Value Change Per Share---0.340-0.008-98%-0.199-41%0.163-309%0.119-386%
Usd Book Value Per Share--4.9745.123-3%4.937+1%4.119+21%2.434+104%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.6160.321+92%0.200+208%0.198+211%0.078+687%
Usd Free Cash Flow--81100000.000127975000.000-37%76175000.000+6%64050000.000+27%34667500.000+134%
Usd Free Cash Flow Per Share--0.1950.301-35%0.180+9%0.155+26%0.084+131%
Usd Free Cash Flow To Equity Per Share---1.3240.099-1438%-0.145-89%0.170-880%0.167-894%
Usd Market Cap51659011072.000+0%51609031000.00048875716500.000+6%83325967500.000-38%106005052754.976-51%67236848828.496-23%
Usd Price Per Share134.000+7%124.090115.520+7%194.978-36%260.287-52%167.066-26%
Usd Profit--256300000.000135375000.000+89%85300000.000+200%81605000.000+214%32730000.000+683%
Usd Revenue--1034500000.000905575000.000+14%727450000.000+42%619165000.000+67%384197500.000+169%
Usd Total Gains Per Share---0.340-0.008-98%-0.199-41%0.163-309%0.119-386%
 EOD+3 -5MRQTTM+15 -18YOY+18 -165Y+19 -1510Y+19 -15

4.2. Fundamental Score

Let's check the fundamental score of DexCom Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1554.361
Price to Book Ratio (EOD)Between0-126.941
Net Profit Margin (MRQ)Greater than00.248
Operating Margin (MRQ)Greater than00.243
Quick Ratio (MRQ)Greater than13.772
Current Ratio (MRQ)Greater than12.844
Debt to Asset Ratio (MRQ)Less than10.670
Debt to Equity Ratio (MRQ)Less than12.028
Return on Equity (MRQ)Greater than0.150.124
Return on Assets (MRQ)Greater than0.050.041
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of DexCom Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.504
Ma 20Greater thanMa 50136.771
Ma 50Greater thanMa 100129.747
Ma 100Greater thanMa 200126.313
OpenGreater thanClose131.470
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Tax Provision  41,400-25,50015,90027,50043,40076,300119,700-129,800-10,100
Income Tax Expense  41,400-25,50015,90027,50043,40076,300119,700-129,800-10,100



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets6,264,500
Total Liabilities4,195,900
Total Stockholder Equity2,068,600
 As reported
Total Liabilities 4,195,900
Total Stockholder Equity+ 2,068,600
Total Assets = 6,264,500

Assets

Total Assets6,264,500
Total Current Assets4,425,900
Long-term Assets1,838,600
Total Current Assets
Cash And Cash Equivalents 566,300
Short-term Investments 2,157,800
Net Receivables 987,500
Inventory 559,600
Other Current Assets 49,300
Total Current Assets  (as reported)4,425,900
Total Current Assets  (calculated)4,320,500
+/- 105,400
Long-term Assets
Property Plant Equipment 1,184,500
Goodwill 25,200
Long Term Investments 38,500
Intangible Assets 134,500
Long-term Assets Other 36,500
Long-term Assets  (as reported)1,838,600
Long-term Assets  (calculated)1,419,200
+/- 419,400

Liabilities & Shareholders' Equity

Total Current Liabilities1,556,000
Long-term Liabilities2,639,900
Total Stockholder Equity2,068,600
Total Current Liabilities
Short-term Debt 21,100
Accounts payable 276,400
Other Current Liabilities 1,240,100
Total Current Liabilities  (as reported)1,556,000
Total Current Liabilities  (calculated)1,537,600
+/- 18,400
Long-term Liabilities
Long term Debt 2,434,200
Capital Lease Obligations 159,800
Long-term Liabilities Other 5,200
Long-term Liabilities  (as reported)2,639,900
Long-term Liabilities  (calculated)2,599,200
+/- 40,700
Total Stockholder Equity
Common Stock400
Retained Earnings 1,021,400
Accumulated Other Comprehensive Income -16,700
Other Stockholders Equity 1,063,500
Total Stockholder Equity (as reported)2,068,600
Total Stockholder Equity (calculated)2,068,600
+/-0
Other
Capital Stock400
Cash and Short Term Investments 2,724,100
Common Stock Shares Outstanding 415,900
Current Deferred Revenue18,400
Liabilities and Stockholders Equity 6,264,500
Net Debt 2,027,700
Net Invested Capital 4,502,800
Net Working Capital 2,869,900
Property Plant and Equipment Gross 1,693,900
Short Long Term Debt Total 2,594,000



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312003-12-31
> Total Assets 
20,767
29,358
25,365
70,077
64,277
56,726
47,488
84,622
75,536
64,553
105,461
96,527
85,489
77,259
68,962
57,053
43,075
44,366
77,946
65,101
53,956
46,948
68,314
60,565
54,105
77,164
66,555
136,369
128,793
120,475
117,962
110,522
102,796
106,000
98,800
102,300
110,100
122,500
124,900
139,700
159,400
184,600
189,300
218,400
256,700
292,000
299,400
332,800
361,900
402,800
467,200
795,600
842,900
904,100
896,800
1,007,500
1,114,300
1,916,000
1,974,000
2,065,900
2,185,700
2,395,000
2,447,900
3,521,800
3,833,200
4,290,500
4,389,800
4,503,800
4,775,900
4,863,600
5,057,000
5,217,400
4,899,200
5,391,700
5,515,900
6,820,700
6,596,200
6,264,500
6,264,5006,596,2006,820,7005,515,9005,391,7004,899,2005,217,4005,057,0004,863,6004,775,9004,503,8004,389,8004,290,5003,833,2003,521,8002,447,9002,395,0002,185,7002,065,9001,974,0001,916,0001,114,3001,007,500896,800904,100842,900795,600467,200402,800361,900332,800299,400292,000256,700218,400189,300184,600159,400139,700124,900122,500110,100102,30098,800106,000102,796110,522117,962120,475128,793136,36966,55577,16454,10560,56568,31446,94853,95665,10177,94644,36643,07557,05368,96277,25985,48996,527105,46164,55375,53684,62247,48856,72664,27770,07725,36529,35820,767
   > Total Current Assets 
0
0
21,910
67,345
60,467
51,013
41,161
77,051
67,944
57,356
96,082
87,519
77,083
67,291
53,847
42,955
29,784
32,058
66,506
54,123
43,376
36,920
59,009
50,443
44,488
66,025
54,432
123,980
115,232
104,410
92,822
83,993
75,571
77,600
71,300
74,200
81,700
93,100
93,600
105,500
123,400
145,900
146,200
170,400
203,700
231,300
227,400
241,000
258,600
280,000
330,500
656,800
692,900
744,700
729,300
836,000
914,100
1,699,500
1,690,800
1,744,200
1,815,700
1,969,400
1,995,700
3,033,000
3,237,100
3,424,800
3,445,100
3,474,200
3,656,200
3,684,400
3,746,600
3,808,700
3,398,500
3,668,800
3,767,400
5,002,900
4,698,400
4,425,900
4,425,9004,698,4005,002,9003,767,4003,668,8003,398,5003,808,7003,746,6003,684,4003,656,2003,474,2003,445,1003,424,8003,237,1003,033,0001,995,7001,969,4001,815,7001,744,2001,690,8001,699,500914,100836,000729,300744,700692,900656,800330,500280,000258,600241,000227,400231,300203,700170,400146,200145,900123,400105,50093,60093,10081,70074,20071,30077,60075,57183,99392,822104,410115,232123,98054,43266,02544,48850,44359,00936,92043,37654,12366,50632,05829,78442,95553,84767,29177,08387,51996,08257,35667,94477,05141,16151,01360,46767,34521,91000
       Cash And Cash Equivalents 
20,016
27,229
4,644
51,490
42,119
37,247
20,181
23,978
23,203
18,167
55,828
25,884
15,176
23,115
23,952
4,963
4,642
12,700
9,276
4,208
6,362
3,577
10,700
6,090
5,529
4,889
3,805
33,889
17,523
2,553
5,119
5,985
4,744
8,100
18,900
28,200
33,400
43,200
45,700
49,500
63,200
71,800
54,200
67,700
85,300
86,100
77,900
87,500
97,700
94,500
153,500
395,900
402,100
441,500
420,400
300,200
367,400
1,137,000
1,285,100
709,200
395,600
446,200
584,600
530,000
673,500
817,600
733,800
1,158,800
1,444,300
1,052,600
716,000
735,400
698,100
642,300
623,200
1,194,900
643,700
566,300
566,300643,7001,194,900623,200642,300698,100735,400716,0001,052,6001,444,3001,158,800733,800817,600673,500530,000584,600446,200395,600709,2001,285,1001,137,000367,400300,200420,400441,500402,100395,900153,50094,50097,70087,50077,90086,10085,30067,70054,20071,80063,20049,50045,70043,20033,40028,20018,9008,1004,7445,9855,1192,55317,52333,8893,8054,8895,5296,09010,7003,5776,3624,2089,27612,7004,6424,96323,95223,11515,17625,88455,82818,16723,20323,97820,18137,24742,11951,4904,64427,22920,016
       Short-term Investments 
0
0
17,108
15,094
17,335
13,278
18,494
48,365
41,474
36,341
37,348
58,316
59,103
41,208
26,632
32,896
20,741
14,368
52,176
44,666
31,356
24,439
39,221
33,991
24,380
42,224
33,526
71,139
79,794
79,358
65,065
55,203
48,641
40,600
26,400
18,200
14,200
11,400
11,700
11,800
11,700
11,800
29,600
29,800
28,000
29,100
28,600
28,100
29,600
29,200
27,600
100,700
123,700
107,100
113,500
305,900
301,300
248,600
72,900
668,300
1,034,300
1,087,100
925,900
1,978,800
1,930,300
1,890,100
1,898,800
1,426,100
1,253,600
1,678,600
1,972,200
2,019,400
1,673,800
1,813,900
1,943,800
2,441,300
2,596,600
2,157,800
2,157,8002,596,6002,441,3001,943,8001,813,9001,673,8002,019,4001,972,2001,678,6001,253,6001,426,1001,898,8001,890,1001,930,3001,978,800925,9001,087,1001,034,300668,30072,900248,600301,300305,900113,500107,100123,700100,70027,60029,20029,60028,10028,60029,10028,00029,80029,60011,80011,70011,80011,70011,40014,20018,20026,40040,60048,64155,20365,06579,35879,79471,13933,52642,22424,38033,99139,22124,43931,35644,66652,17614,36820,74132,89626,63241,20859,10358,31637,34836,34141,47448,36518,49413,27817,33515,09417,10800
       Net Receivables 
0
0
0
0
0
0
0
91
119
120
198
126
171
215
321
568
429
1,118
1,345
2,067
2,487
3,490
3,801
4,661
5,102
6,671
7,158
8,694
9,003
12,547
12,543
12,900
12,357
19,500
16,300
17,700
21,600
26,100
23,800
28,600
31,400
42,400
40,200
45,500
55,800
74,100
67,300
73,800
76,800
101,700
85,900
101,700
110,500
134,300
123,900
162,000
169,800
226,700
204,700
217,300
234,900
286,300
300,700
296,500
370,000
428,500
443,400
483,500
529,100
514,300
544,500
612,000
597,100
713,300
652,500
750,600
785,700
987,500
987,500785,700750,600652,500713,300597,100612,000544,500514,300529,100483,500443,400428,500370,000296,500300,700286,300234,900217,300204,700226,700169,800162,000123,900134,300110,500101,70085,900101,70076,80073,80067,30074,10055,80045,50040,20042,40031,40028,60023,80026,10021,60017,70016,30019,50012,35712,90012,54312,5479,0038,6947,1586,6715,1024,6613,8013,4902,4872,0671,3451,118429568321215171126198120119910000000
       Inventory 
0
0
0
0
0
0
1,920
3,208
1,937
1,413
1,457
1,254
1,035
1,139
1,824
2,771
2,590
2,446
2,365
1,363
1,932
2,641
3,851
4,087
6,353
8,112
6,425
6,258
6,455
8,171
8,044
7,378
7,141
7,400
7,500
7,300
10,000
9,000
8,900
11,600
14,300
16,000
18,400
22,400
30,600
35,200
46,100
42,900
44,700
45,400
46,500
42,800
43,300
45,200
51,600
46,200
55,200
70,700
101,100
117,900
120,400
119,800
141,900
165,300
200,700
234,700
289,700
319,300
351,300
357,300
342,200
339,500
311,000
306,700
366,000
421,100
498,600
559,600
559,600498,600421,100366,000306,700311,000339,500342,200357,300351,300319,300289,700234,700200,700165,300141,900119,800120,400117,900101,10070,70055,20046,20051,60045,20043,30042,80046,50045,40044,70042,90046,10035,20030,60022,40018,40016,00014,30011,6008,9009,00010,0007,3007,5007,4007,1417,3788,0448,1716,4556,2586,4258,1126,3534,0873,8512,6411,9321,3632,3652,4462,5902,7711,8241,1391,0351,2541,4571,4131,9373,2081,920000000
   > Long-term Assets 
0
0
3,455
2,732
3,810
5,713
6,326
7,571
7,592
7,197
9,379
9,008
8,406
9,968
15,115
14,098
13,291
12,308
11,440
10,978
10,580
10,028
9,305
10,122
9,617
11,139
12,123
12,389
13,561
16,065
25,140
26,529
27,225
28,400
27,500
28,100
28,400
29,400
31,300
34,200
36,000
38,700
43,100
48,000
53,000
60,700
72,000
91,800
103,300
122,800
136,700
138,800
150,000
159,400
167,500
171,500
200,200
216,500
283,200
321,700
370,000
425,600
452,200
488,800
596,100
865,700
944,700
1,029,600
1,119,700
1,179,200
1,310,400
1,408,700
1,500,700
1,722,900
1,748,500
1,817,800
1,897,800
1,838,600
1,838,6001,897,8001,817,8001,748,5001,722,9001,500,7001,408,7001,310,4001,179,2001,119,7001,029,600944,700865,700596,100488,800452,200425,600370,000321,700283,200216,500200,200171,500167,500159,400150,000138,800136,700122,800103,30091,80072,00060,70053,00048,00043,10038,70036,00034,20031,30029,40028,40028,10027,50028,40027,22526,52925,14016,06513,56112,38912,12311,1399,61710,1229,30510,02810,58010,97811,44012,30813,29114,09815,1159,9688,4069,0089,3797,1977,5927,5716,3265,7133,8102,7323,45500
       Property Plant Equipment 
611
1,852
1,929
2,482
3,560
5,463
6,026
6,657
6,678
6,118
5,819
5,565
5,058
6,649
6,854
6,543
6,442
6,105
6,403
6,495
6,731
6,422
6,880
7,775
9,240
10,763
11,748
12,016
12,524
15,019
16,206
17,768
18,613
18,900
18,300
19,100
19,700
20,700
22,900
26,000
28,000
31,200
35,700
40,600
46,600
54,700
65,900
77,000
88,400
109,400
123,400
125,000
136,100
145,600
152,400
156,800
169,600
183,100
249,100
289,000
335,600
392,800
419,900
455,900
556,100
608,600
688,700
770,800
833,500
889,900
938,800
1,020,800
1,075,600
1,135,600
1,153,500
1,153,900
1,152,300
1,184,500
1,184,5001,152,3001,153,9001,153,5001,135,6001,075,6001,020,800938,800889,900833,500770,800688,700608,600556,100455,900419,900392,800335,600289,000249,100183,100169,600156,800152,400145,600136,100125,000123,400109,40088,40077,00065,90054,70046,60040,60035,70031,20028,00026,00022,90020,70019,70019,10018,30018,90018,61317,76816,20615,01912,52412,01611,74810,7639,2407,7756,8806,4226,7316,4956,4036,1056,4426,5436,8546,6495,0585,5655,8196,1186,6786,6576,0265,4633,5602,4821,9291,852611
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,162
3,162
3,162
3,200
3,200
3,200
3,200
3,200
3,200
3,200
3,200
3,200
3,200
3,700
3,700
3,700
3,700
11,800
11,800
11,300
11,400
11,900
12,000
12,100
12,300
11,900
18,400
18,700
18,600
18,700
18,400
18,600
18,600
18,700
19,000
19,300
18,900
19,100
23,900
26,500
26,600
25,600
24,700
25,700
25,700
25,800
25,300
25,200
25,20025,30025,80025,70025,70024,70025,60026,60026,50023,90019,10018,90019,30019,00018,70018,60018,60018,40018,70018,60018,70018,40011,90012,30012,10012,00011,90011,40011,30011,80011,8003,7003,7003,7003,7003,2003,2003,2003,2003,2003,2003,2003,2003,2003,2003,1623,1623,162000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,100
4,500
5,900
1,800
17,200
19,800
14,400
1,500
1,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,000
0
0
38,500
38,500
38,50038,5000019,000000000000000000001,0001,50014,40019,80017,2001,8005,9004,5001,10000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,610
4,462
4,313
4,200
4,000
3,900
3,700
3,600
3,400
3,300
3,100
2,700
2,600
2,500
2,400
2,200
2,000
1,800
1,600
200
11,400
11,900
12,000
12,100
12,300
11,900
18,400
0
0
0
0
0
0
0
0
0
0
0
46,000
42,000
31,400
28,000
24,400
173,300
163,600
154,200
144,500
134,500
134,500144,500154,200163,600173,30024,40028,00031,40042,00046,0000000000000018,40011,90012,30012,10012,00011,90011,4002001,6001,8002,0002,2002,4002,5002,6002,7003,1003,3003,4003,6003,7003,9004,0004,2004,3134,4624,610000000000000000000000000000000
       Long-term Assets Other 
0
0
1,526
250
250
250
300
914
914
1,079
3,560
3,443
3,348
3,319
8,261
7,555
6,849
6,203
5,037
4,483
3,849
3,606
2,425
2,347
377
376
375
373
1,037
1,046
1,162
1,137
1,137
2,100
2,000
1,900
1,800
1,900
1,800
1,700
1,700
1,600
1,600
1,200
300
100
400
1,200
1,500
1,900
1,900
1,900
1,900
1,700
2,800
2,800
12,200
14,700
15,500
14,000
16,000
14,200
13,700
14,200
21,000
21,400
20,400
23,300
1,000
220,800
22,800
24,800
6,900
28,100
37,600
31,900
35,900
36,500
36,50035,90031,90037,60028,1006,90024,80022,800220,8001,00023,30020,40021,40021,00014,20013,70014,20016,00014,00015,50014,70012,2002,8002,8001,7001,9001,9001,9001,9001,5001,2004001003001,2001,6001,6001,7001,7001,8001,9001,8001,9002,0002,1001,1371,1371,1621,0461,0373733753763772,3472,4253,6063,8494,4835,0376,2036,8497,5558,2613,3193,3483,4433,5601,0799149143002502502501,52600
> Total Liabilities 
984
1,693
80,012
3,015
3,161
7,314
7,206
6,615
9,191
7,724
69,059
69,850
68,165
70,144
71,854
71,761
70,368
82,979
62,792
63,124
63,057
65,393
21,587
19,547
18,861
16,171
13,193
14,794
15,728
15,985
18,411
19,214
22,543
29,000
25,200
30,000
35,400
38,400
34,900
40,100
44,400
44,400
40,700
47,700
63,400
70,800
68,200
86,400
100,100
119,000
189,400
441,900
458,900
484,700
475,100
525,400
552,100
1,252,700
1,305,400
1,377,600
1,421,400
1,512,400
1,513,400
2,167,900
2,333,900
2,464,000
2,486,600
2,506,200
2,639,800
2,612,100
2,867,700
2,961,500
3,074,700
3,259,900
3,282,900
4,720,300
4,328,300
4,195,900
4,195,9004,328,3004,720,3003,282,9003,259,9003,074,7002,961,5002,867,7002,612,1002,639,8002,506,2002,486,6002,464,0002,333,9002,167,9001,513,4001,512,4001,421,4001,377,6001,305,4001,252,700552,100525,400475,100484,700458,900441,900189,400119,000100,10086,40068,20070,80063,40047,70040,70044,40044,40040,10034,90038,40035,40030,00025,20029,00022,54319,21418,41115,98515,72814,79413,19316,17118,86119,54721,58765,39363,05763,12462,79282,97970,36871,76171,85470,14468,16569,85069,0597,7249,1916,6157,2067,3143,1613,01580,0121,693984
   > Total Current Liabilities 
984
1,568
2,798
2,869
2,919
7,074
6,968
4,924
6,568
5,229
6,498
7,447
6,107
8,447
8,097
8,609
7,827
14,996
14,997
16,624
17,535
18,796
15,828
15,514
17,008
15,129
11,595
13,776
14,743
14,741
16,076
16,961
20,404
19,500
16,200
21,100
27,400
32,100
29,700
35,600
40,600
40,600
37,000
44,200
58,800
66,900
64,100
73,900
86,100
102,400
171,700
105,100
118,200
138,900
125,100
170,800
193,900
222,400
235,400
288,200
322,400
360,200
342,800
400,100
506,400
614,100
604,100
600,700
734,900
720,800
711,400
807,000
900,500
1,839,300
1,865,000
2,069,700
1,678,600
1,556,000
1,556,0001,678,6002,069,7001,865,0001,839,300900,500807,000711,400720,800734,900600,700604,100614,100506,400400,100342,800360,200322,400288,200235,400222,400193,900170,800125,100138,900118,200105,100171,700102,40086,10073,90064,10066,90058,80044,20037,00040,60040,60035,60029,70032,10027,40021,10016,20019,50020,40416,96116,07614,74114,74313,77611,59515,12917,00815,51415,82818,79617,53516,62414,99714,9967,8278,6098,0978,4476,1077,4476,4985,2296,5684,9246,9687,0742,9192,8692,7981,568984
       Short-term Debt 
0
0
0
0
0
0
0
150
540
908
1,289
1,375
1,375
1,375
2,275
2,275
2,275
1,931
1,588
1,244
900
900
900
900
750
525
300
75
0
0
641
832
969
200
700
1,200
1,800
2,200
2,200
2,300
2,300
2,300
2,400
2,400
2,500
2,300
1,700
3,300
3,700
-39,100
75,000
13,600
10,600
-33,400
-40,300
15,400
18,300
-59,900
12,300
14,100
14,800
13,600
14,500
15,100
15,800
16,500
18,200
18,800
19,300
20,500
20,900
21,200
20,900
793,100
795,400
795,600
145,200
21,100
21,100145,200795,600795,400793,10020,90021,20020,90020,50019,30018,80018,20016,50015,80015,10014,50013,60014,80014,10012,300-59,90018,30015,400-40,300-33,40010,60013,60075,000-39,1003,7003,3001,7002,3002,5002,4002,4002,3002,3002,3002,2002,2001,8001,20070020096983264100753005257509009009009001,2441,5881,9312,2752,2752,2751,3751,3751,3751,2899085401500000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,300
0
0
0
2,300
0
75,000
75,000
6,700
75,000
327,200
330,700
334,300
338,700
342,300
0
0
12,300
0
0
0
0
0
0
0
0
0
0
0
0
0
0
772,600
773,200
773,800
124,200
0
0124,200773,800773,200772,6000000000000000012,30000342,300338,700334,300330,700327,20075,0006,70075,00075,00002,3000002,30000000000000000000000000000000000000000000
       Accounts payable 
692
1,019
1,203
2,136
1,969
6,008
4,821
2,216
3,065
835
3,018
3,966
2,088
1,532
3,245
1,239
2,663
1,123
1,368
956
2,024
2,600
2,173
2,212
4,138
1,758
2,001
2,083
2,652
2,807
1,952
2,021
3,796
3,900
2,200
2,800
3,800
4,200
4,800
7,000
7,900
20,400
21,200
11,700
16,700
38,900
21,500
22,400
26,300
68,100
17,900
16,800
23,300
87,200
88,000
59,900
57,700
147,100
90,300
196,700
101,400
256,400
110,200
315,900
147,600
163,300
152,200
165,900
210,000
573,000
150,100
219,600
198,100
901,800
266,200
1,156,500
1,373,100
276,400
276,4001,373,1001,156,500266,200901,800198,100219,600150,100573,000210,000165,900152,200163,300147,600315,900110,200256,400101,400196,70090,300147,10057,70059,90088,00087,20023,30016,80017,90068,10026,30022,40021,50038,90016,70011,70021,20020,4007,9007,0004,8004,2003,8002,8002,2003,9003,7962,0211,9522,8072,6522,0832,0011,7584,1382,2122,1732,6002,0249561,3681,1232,6631,2393,2451,5322,0883,9663,0188353,0652,2164,8216,0081,9692,1361,2031,019692
       Other Current Liabilities 
292
549
1,595
733
949
1,066
2,146
2,558
2,963
3,486
2,191
2,106
2,644
5,540
2,410
4,928
2,722
5,591
4,593
6,320
5,909
7,551
6,987
8,355
8,560
9,322
6,936
9,285
10,354
10,343
11,638
12,609
14,417
14,000
12,500
16,400
21,200
25,000
22,100
26,000
29,800
17,200
12,100
29,300
38,000
24,900
40,300
47,500
55,600
72,500
77,600
73,200
82,000
81,900
74,500
88,700
114,400
132,300
130,100
73,900
201,900
88,500
216,300
67,400
341,500
432,100
431,800
414,200
503,300
125,200
537,700
563,500
678,800
134,300
793,800
108,600
151,300
1,240,100
1,240,100151,300108,600793,800134,300678,800563,500537,700125,200503,300414,200431,800432,100341,50067,400216,30088,500201,90073,900130,100132,300114,40088,70074,50081,90082,00073,20077,60072,50055,60047,50040,30024,90038,00029,30012,10017,20029,80026,00022,10025,00021,20016,40012,50014,00014,41712,60911,63810,34310,3549,2856,9369,3228,5608,3556,9877,5515,9096,3204,5935,5912,7224,9282,4105,5402,6442,1062,1913,4862,9632,5582,1461,0669497331,595549292
   > Long-term Liabilities 
0
0
77,214
147
242
240
238
1,691
2,622
2,496
62,561
62,403
62,058
61,697
63,757
63,152
62,541
67,983
47,795
46,500
45,522
46,597
5,759
4,033
1,853
1,042
1,598
1,018
985
1,244
2,335
2,253
2,139
9,500
9,000
8,900
8,000
6,300
5,200
4,500
3,800
3,800
3,700
3,500
4,600
3,900
4,100
12,500
14,000
16,600
17,700
336,800
340,700
345,800
350,000
354,600
358,200
1,030,300
1,070,000
1,089,400
1,099,000
1,152,200
1,170,600
1,767,800
1,827,500
1,849,900
1,882,500
1,905,500
1,904,900
1,891,300
2,156,300
2,154,500
2,174,200
1,420,600
1,417,900
2,650,600
2,649,700
2,639,900
2,639,9002,649,7002,650,6001,417,9001,420,6002,174,2002,154,5002,156,3001,891,3001,904,9001,905,5001,882,5001,849,9001,827,5001,767,8001,170,6001,152,2001,099,0001,089,4001,070,0001,030,300358,200354,600350,000345,800340,700336,80017,70016,60014,00012,5004,1003,9004,6003,5003,7003,8003,8004,5005,2006,3008,0008,9009,0009,5002,1392,2532,3351,2449851,0181,5981,0421,8534,0335,75946,59745,52246,50047,79567,98362,54163,15263,75761,69762,05862,40362,5612,4962,6221,69123824024214777,21400
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,800
6,300
5,800
5,200
4,600
4,100
3,500
2,900
2,300
1,700
1,100
400
0
0
0
0
0
0
320,500
324,000
327,600
331,300
335,000
338,800
1,010,300
1,022,400
1,034,700
1,047,100
1,059,700
1,072,400
1,658,800
1,645,800
1,667,200
1,688,800
1,710,700
1,703,500
1,702,700
1,965,900
1,967,300
1,968,800
1,197,700
1,198,500
2,430,600
0
0
002,430,6001,198,5001,197,7001,968,8001,967,3001,965,9001,702,7001,703,5001,710,7001,688,8001,667,2001,645,8001,658,8001,072,4001,059,7001,047,1001,034,7001,022,4001,010,300338,800335,000331,300327,600324,000320,5000000004001,1001,7002,3002,9003,5004,1004,6005,2005,8006,3006,800000000000000000000000000000000000
       Other Liabilities 
0
125
133
147
242
240
238
341
462
378
412
684
683
666
969
933
891
6,558
5,089
2,833
839
840
791
750
1,853
1,042
1,598
1,018
985
1,244
2,335
2,253
2,139
2,700
2,700
3,100
2,800
1,700
1,100
1,000
900
1,500
2,000
2,400
4,200
3,900
4,100
6,500
8,000
16,600
11,000
9,600
10,000
11,500
11,300
12,300
12,100
12,700
2,900
2,800
3,100
5,700
6,700
21,300
24,800
80,900
28,200
30,300
98,500
90,000
35,500
38,200
62,900
68,700
0
0
76,000
0
076,0000068,70062,90038,20035,50090,00098,50030,30028,20080,90024,80021,3006,7005,7003,1002,8002,90012,70012,10012,30011,30011,50010,0009,60011,00016,6008,0006,5004,1003,9004,2002,4002,0001,5009001,0001,1001,7002,8003,1002,7002,7002,1392,2532,3351,2449851,0181,5981,0421,8537507918408392,8335,0896,5588919339696666836844123784623412382402421471331250
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
281
834
702
569
600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000060056970283428100000000000000000000000000000
> Total Stockholder Equity
19,783
27,665
-54,647
67,061
61,117
49,412
40,282
78,007
66,346
56,828
36,402
26,677
17,324
7,115
-2,892
-14,708
-27,293
-38,613
15,154
1,977
-9,101
-18,445
46,727
41,018
35,244
60,993
53,362
121,575
113,065
104,490
99,551
91,308
80,253
77,000
73,600
72,300
74,700
84,100
90,000
99,600
115,000
140,200
148,600
170,700
193,300
221,200
231,200
246,400
261,800
283,800
277,800
353,700
384,000
419,400
421,700
482,100
562,200
663,300
668,600
688,300
764,300
882,600
934,500
1,353,900
1,499,300
1,826,500
1,903,200
1,997,600
2,136,100
2,251,500
2,189,300
2,255,900
1,824,500
2,131,800
2,233,000
2,100,400
2,267,900
2,068,600
2,068,6002,267,9002,100,4002,233,0002,131,8001,824,5002,255,9002,189,3002,251,5002,136,1001,997,6001,903,2001,826,5001,499,3001,353,900934,500882,600764,300688,300668,600663,300562,200482,100421,700419,400384,000353,700277,800283,800261,800246,400231,200221,200193,300170,700148,600140,200115,00099,60090,00084,10074,70072,30073,60077,00080,25391,30899,551104,490113,065121,57553,36260,99335,24441,01846,727-18,445-9,1011,97715,154-38,613-27,293-14,708-2,8927,11517,32426,67736,40256,82866,34678,00740,28249,41261,11767,061-54,64727,66519,783
   Common Stock
2
2
3
25
25
25
26
28
28
28
28
28
28
29
30
30
30
30
46
46
46
46
58
58
60
62
63
68
68
68
69
69
70
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
400
400
400
400
400
400
400
400400400400400400400100100100100100100100100100100100100100100100100100100100100100100100100100100100100100100100100100100100100100100706969686868636260585846464646303030302928282828282826252525322
   Retained Earnings Total Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-365,595
-378,873
-391,124
-405,188
-419,879
-437,142
-445,600
-456,700
-466,800
-472,800
-475,400
-487,900
-493,900
-499,100
-497,800
-510,700
-514,400
-556,900
-555,400
-574,600
-594,800
-613,600
-621,000
-663,300
-660,400
-662,400
-671,800
-696,000
-665,800
-619,200
-798,900
-823,700
-834,200
-788,400
-695,700
-675,800
-629,500
-557,300
-202,100
-161,800
-98,900
-28,000
-47,400
236,000
286,900
388,100
479,900
528,500
644,400
0
0
00644,400528,500479,900388,100286,900236,000-47,400-28,000-98,900-161,800-202,100-557,300-629,500-675,800-695,700-788,400-834,200-823,700-798,900-619,200-665,800-696,000-671,800-662,400-660,400-663,300-621,000-613,600-594,800-574,600-555,400-556,900-514,400-510,700-497,800-499,100-493,900-487,900-475,400-472,800-466,800-456,700-445,600-437,142-419,879-405,188-391,124-378,873-365,595000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
-2,222
-1,778
-1,385
-1,096
-16
-63
2
12
8
-33
34
13
53
-45
-81
50
13
63
36
-13
-40
-5
-39
-66
-83
-101
-94
-80
-103
-88
-93
-100
-100
-100
-100
-100
-100
-200
-100
-100
-300
-300
-300
-300
-300
-700
-700
-1,000
-1,300
-1,600
-2,200
-2,600
-4,900
-1,300
-300
1,500
1,600
2,000
1,000
2,300
3,700
3,500
2,800
3,200
2,900
2,800
1,400
500
-6,100
-23,000
-41,100
-11,600
-6,500
-29,300
-35,600
-16,700
-16,700-35,600-29,300-6,500-11,600-41,100-23,000-6,1005001,4002,8002,9003,2002,8003,5003,7002,3001,0002,0001,6001,500-300-1,300-4,900-2,600-2,200-1,600-1,300-1,000-700-700-300-300-300-300-300-100-100-200-100-100-100-100-100-100-93-88-103-80-94-101-83-66-39-5-40-1336631350-81-45531334-338122-63-16-1,096-1,385-1,778-2,22200
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
487,203
491,964
495,626
504,773
511,206
517,418
522,600
530,300
539,100
547,500
559,500
577,900
593,600
614,100
638,000
659,500
685,300
750,400
776,800
806,000
841,800
876,000
905,700
942,300
1,015,600
1,048,500
1,093,700
1,122,500
1,149,100
1,181,600
1,560,600
1,590,600
1,620,400
1,651,600
1,675,900
1,706,500
2,079,800
2,153,700
2,125,300
2,162,000
2,193,600
2,322,100
2,504,500
1,996,600
2,028,900
2,072,100
2,258,100
2,305,600
2,269,000
0
0
002,269,0002,305,6002,258,1002,072,1002,028,9001,996,6002,504,5002,322,1002,193,6002,162,0002,125,3002,153,7002,079,8001,706,5001,675,9001,651,6001,620,4001,590,6001,560,6001,181,6001,149,1001,122,5001,093,7001,048,5001,015,600942,300905,700876,000841,800806,000776,800750,400685,300659,500638,000614,100593,600577,900559,500547,500539,100530,300522,600517,418511,206504,773495,626491,964487,203000000000000000000000000000
   Treasury Stock000000-37,300-37,300-206,200-159,500-100,000-100,000-100,000-100,000-100,000-100,000-100,000-100,000-100,000-100,000-100,00000000000000000000000000-77,000-80,253-91,3080000000000000000000000000000000
   Other Stockholders Equity 
0
0
6,547
64,115
69,906
134,257
134,966
183,904
185,615
187,162
177,669
179,321
181,285
183,325
186,249
188,605
190,744
192,743
265,921
268,024
270,496
272,730
358,190
364,133
371,789
407,375
411,610
487,203
491,964
495,626
504,773
511,206
517,418
522,600
530,300
539,100
547,500
559,500
577,900
593,600
614,100
638,000
659,500
685,300
750,400
776,800
806,000
841,800
876,000
905,700
942,300
1,015,600
1,048,500
1,093,700
1,122,500
1,149,100
1,181,600
1,460,600
1,490,600
1,520,400
1,551,600
1,575,900
1,606,500
1,979,800
2,053,700
2,025,300
2,062,000
2,093,600
2,162,600
2,298,300
1,959,300
1,991,600
1,477,100
1,663,100
1,710,600
1,484,900
1,538,000
1,063,500
1,063,5001,538,0001,484,9001,710,6001,663,1001,477,1001,991,6001,959,3002,298,3002,162,6002,093,6002,062,0002,025,3002,053,7001,979,8001,606,5001,575,9001,551,6001,520,4001,490,6001,460,6001,181,6001,149,1001,122,5001,093,7001,048,5001,015,600942,300905,700876,000841,800806,000776,800750,400685,300659,500638,000614,100593,600577,900559,500547,500539,100530,300522,600517,418511,206504,773495,626491,964487,203411,610407,375371,789364,133358,190272,730270,496268,024265,921192,743190,744188,605186,249183,325181,285179,321177,669187,162185,615183,904134,966134,25769,90664,1156,54700



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,622,300
Cost of Revenue-1,333,400
Gross Profit2,288,9002,288,900
 
Operating Income (+$)
Gross Profit2,288,900
Operating Expense-1,691,200
Operating Income597,700597,700
 
Operating Expense (+$)
Research Development505,800
Selling General Administrative1,185,400
Selling And Marketing Expenses0
Operating Expense1,691,2001,691,200
 
Net Interest Income (+$)
Interest Income135,000
Interest Expense-20,300
Other Finance Cost-0
Net Interest Income114,700
 
Pretax Income (+$)
Operating Income597,700
Net Interest Income114,700
Other Non-Operating Income Expenses0
Income Before Tax (EBT)710,400599,700
EBIT - interestExpense = 710,400
710,400
561,800
Interest Expense20,300
Earnings Before Interest and Taxes (EBIT)730,700730,700
Earnings Before Interest and Taxes (EBITDA)916,700
 
After tax Income (+$)
Income Before Tax710,400
Tax Provision-168,900
Net Income From Continuing Ops541,500541,500
Net Income541,500
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses3,024,600
Total Other Income/Expenses Net-2,000-114,700
 

Technical Analysis of Dexcom
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Dexcom. The general trend of Dexcom is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Dexcom's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of DexCom Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 131.74 < 141.99 < 142.00.

The bearish price targets are: 130.31 > 128.62 > 127.37.

Tweet this
DexCom Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of DexCom Inc. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

DexCom Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of DexCom Inc. The current macd is 0.36415432.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Dexcom price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Dexcom. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Dexcom price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
DexCom Inc Daily Moving Average Convergence/Divergence (MACD) ChartDexCom Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of DexCom Inc. The current adx is 20.92.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Dexcom shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
DexCom Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of DexCom Inc. The current sar is 139.72.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
DexCom Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of DexCom Inc. The current rsi is 49.50. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
DexCom Inc Daily Relative Strength Index (RSI) ChartDexCom Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of DexCom Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Dexcom price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
DexCom Inc Daily Stochastic Oscillator ChartDexCom Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of DexCom Inc. The current cci is -97.51809313.

DexCom Inc Daily Commodity Channel Index (CCI) ChartDexCom Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of DexCom Inc. The current cmo is -5.95578856.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
DexCom Inc Daily Chande Momentum Oscillator (CMO) ChartDexCom Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of DexCom Inc. The current willr is -62.32449298.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Dexcom is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
DexCom Inc Daily Williams %R ChartDexCom Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of DexCom Inc.

DexCom Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of DexCom Inc. The current atr is 4.03846471.

DexCom Inc Daily Average True Range (ATR) ChartDexCom Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of DexCom Inc. The current obv is -19,353,273.

DexCom Inc Daily On-Balance Volume (OBV) ChartDexCom Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of DexCom Inc. The current mfi is 48.57.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
DexCom Inc Daily Money Flow Index (MFI) ChartDexCom Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for DexCom Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

DexCom Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of DexCom Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.504
Ma 20Greater thanMa 50136.771
Ma 50Greater thanMa 100129.747
Ma 100Greater thanMa 200126.313
OpenGreater thanClose131.470
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Dexcom with someone you think should read this too:
  • Are you bullish or bearish on Dexcom? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Dexcom? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about DexCom Inc

I send you an email if I find something interesting about DexCom Inc.


Comments

How you think about this?

Leave a comment

Stay informed about DexCom Inc.

Receive notifications about DexCom Inc in your mailbox!